Sutro Biopharma, Inc.
STRO· Nasdaq
Sutro Biopharma, Inc.
- Last sale
- Oct 1, 2026 · -1.17%
- Market cap
- $265.30M
- 16.58M shares
- Filings
- 624
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $102,484,000 | reported | |
| FY 2024 | 2024-12-31 | $62,043,000 | reported | |
| FY 2023 | 2023-12-31 | $153,731,000 | reported | |
| FY 2022 | 2022-12-31 | $67,772,000 | reported | |
| FY 2021 | 2021-12-31 | $61,880,000 | reported | |
| FY 2020 | 2020-12-31 | $42,722,000 | reported | |
| FY 2019 | 2019-12-31 | $42,736,000 | reported | |
| FY 2018 | 2018-12-31 | $38,419,000 | reported | |
| FY 2017 | 2017-12-31 | $51,741,000 | reported | |
| FY 2016 | 2016-12-31 | $59,731,000 | reported |
Sutro Biopharma, Inc. · CIK 1382101 · Engraved from SEC EDGAR
